DOCSLIB.ORG

ACR Coding Handbook 2011 (FORDS, 2011 and ACR Supplement)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ACR Coding Handbook 2011 (FORDS, 2011 and ACR Supplement) Arizona Cancer Registry Coding Handbook Includes: Commission on Cancer FORDS Facility Oncology Registry Data Standards Revised for 2011 and the Arizona Cancer Registry Supplement Effective for Cases Diagnosed January 1, 2011 ARIZONA CANCER REGISTRY SUPPLEMENT 7th EDITION PREPARED BY GEORGIA YEE, BSW, CTR BUREAU OF PUBLIC HEALTH STATISTICS OFFICE OF HEALTH REGISTRIES ARIZONA CANCER REGISTRY 150 N 18th AVE STE 550, PHOENIX AZ 85007 This page intentionally left blank. ACR Supplement Page The Arizona Cancer Registry wishes to thank the Commission on Cancer for allowing the ACR to use and distribute an electronic version of the FORDS. All ACR pages are clearly marked with ACR Supplement in the top header and all ACR notations on CoC pages are in text boxes and in a blue font. Bookmarks added by ACR are also in a blue font. Questions about the content may be directed to the Arizona Cancer Registry at 602-542-7320. This page intentionally left blank. ACR Supplement Page This page intentionally left blank. ACR Supplement Page FORDS Facility Oncology Registry Data Standards Revised for 2011 (Incorporates all updates since FORDS was originally published in July 2002) Includes updates to January 1, 2011 See Appendix C for a summary of changes. © 2002 AMERICAN COLLEGE OF SURGEONS All Rights Reserved ii Table of Contents Preface 2010.......................................................................................................................... xi SECTION ONE: Case Eligibility and Overview of Coding Principles........................... 1–31 Case Eligibility ............................................................................................................... 3 Tumors Required by the CoC to be Accessioned, Abstracted, and Followed........... 3 Reportable-by-Agreement Cases............................................................................... 3 Ambiguous Terms at Diagnosis................................................................................. 3 Class of Case.............................................................................................................. 5 Date of First Contact.................................................................................................. 5 Overview of Coding Principles ..................................................................................... 7 Unique Patient Identifier Codes................................................................................. 7 National Provider Identifier....................................................................................... 7 Coding Dates.............................................................................................................. 7 Cancer Identification.................................................................................................. 8 Patient Address and Residency Rules........................................................................ 13 In Utero Diagnosis and Treatment............................................................................. 14 Comorbidities and Complications ............................................................................. 14 Stage of Disease at Initial Diagnosis ......................................................................... 15 AJCC TNM Staging................................................................................................... 15 Collaborative Staging................................................................................................ 17 First Course of Treatment .......................................................................................... 19 Treatment, Palliative, and Prophylactic Care ............................................................ 27 Embolization.............................................................................................................. 28 Outcomes ................................................................................................................... 28 Case Administration .................................................................................................. 29 SECTION TWO: Coding Instructions ..............................................................................33–356 Patient Identification ..................................................................................................... 35-88 Accession Number..................................................................................................... 37 Sequence Number ...................................................................................................... 38 Medical Record Number............................................................................................ 40 Social Security Number ............................................................................................. 41 Last Name .................................................................................................................. 42 First Name.................................................................................................................. 43 Middle Name (Middle Initial).................................................................................... 44 Patient Address (Number and Street) at Diagnosis ................................................... 45 Patient Address at Diagnosis–Supplemental ............................................................. 46 City/Town at Diagnosis (City or Town).................................................................... 47 State at Diagnosis (State)........................................................................................... 48 Postal Code at Diagnosis (ZIP Code) ........................................................................ 50 County at Diagnosis................................................................................................... 51 iii Patient Identification (continued) Patient Address (Number and Street)–Current .......................................................... 52 Patient Address–Current–Supplemental.................................................................... 53 City/Town–Current.................................................................................................... 54 State–Current ............................................................................................................. 55 Postal Code–Current (ZIP Code)............................................................................... 57 Telephone................................................................................................................... 58 Place of Birth............................................................................................................. 59 Date of Birth.............................................................................................................. 60 Date of Birth Flag ...................................................................................................... 61 Age at Diagnosis........................................................................................................ 62 Race 1......................................................................................................................... 63 Race 2......................................................................................................................... 65 Race 3......................................................................................................................... 66 Race 4......................................................................................................................... 67 Race 5......................................................................................................................... 68 Spanish Origin–All Sources (Spanish/Hispanic Origin) ........................................... 69 Sex.............................................................................................................................. 70 Primary Payer at Diagnosis........................................................................................ 71 Comorbidities and Complications #1 ........................................................................ 73 Comorbidities and Complications #2 ........................................................................ 75 Comorbidities and Complications #3 ........................................................................ 76 Comorbidities and Complications #4 ........................................................................ 77 Comorbidities and Complications #5 ........................................................................ 78 Comorbidities and Complications #6 ........................................................................ 79 Comorbidities and Complications #7 ........................................................................ 80 Comorbidities and Complications #8 ........................................................................ 81 Comorbidities and Complications #9 ........................................................................ 82 Comorbidities and Complications #10 ...................................................................... 83 NPI–Managing Physician.......................................................................................... 84 NPI–Following Physician.......................................................................................... 85 NPI–Primary Surgeon...............................................................................................
Load more

Recommended publications
  • Human Anatomy As Related to Tumor Formation Book Four
    SEER Program Self Instructional Manual for Cancer Registrars Human Anatomy as Related to Tumor Formation Book Four Second Edition U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutesof Health SEER PROGRAM SELF-INSTRUCTIONAL MANUAL FOR CANCER REGISTRARS Book 4 - Human Anatomy as Related to Tumor Formation Second Edition Prepared by: SEER Program Cancer Statistics Branch National Cancer Institute Editor in Chief: Evelyn M. Shambaugh, M.A., CTR Cancer Statistics Branch National Cancer Institute Assisted by Self-Instructional Manual Committee: Dr. Robert F. Ryan, Emeritus Professor of Surgery Tulane University School of Medicine New Orleans, Louisiana Mildred A. Weiss Los Angeles, California Mary A. Kruse Bethesda, Maryland Jean Cicero, ART, CTR Health Data Systems Professional Services Riverdale, Maryland Pat Kenny Medical Illustrator for Division of Research Services National Institutes of Health CONTENTS BOOK 4: HUMAN ANATOMY AS RELATED TO TUMOR FORMATION Page Section A--Objectives and Content of Book 4 ............................... 1 Section B--Terms Used to Indicate Body Location and Position .................. 5 Section C--The Integumentary System ..................................... 19 Section D--The Lymphatic System ....................................... 51 Section E--The Cardiovascular System ..................................... 97 Section F--The Respiratory System ....................................... 129 Section G--The Digestive System ......................................... 163 Section
    [Show full text]
  • Collaborative Stage Manual Part II
    SEER Program Coding and Staging Manual 2004, Revision 1 Collaborative Staging Codes Nasal Cavity C30.0 C30.0 Nasal cavity (excludes nose, NOS C76.0) Note: Laterality must be coded for this site, except subsites Nasal cartilage and Nasal septum, for which laterality is coded 0. CS Tumor Size CS Site-Specific Factor 1 - Size of The following tables are available CS Extension Lymph Nodes at the collaborative staging CS TS/Ext-Eval CS Site-Specific Factor 2 - website: CS Lymph Nodes Extracapsular Extension, Lymph Nodes Histology Exclusion Table CS Reg Nodes Eval for Head and Neck AJCC Stage Reg LN Pos CS Site-Specific Factor 3 - Levels I- Lymph Nodes Size Table Reg LN Exam III, Lymph Nodes for Head and Neck CS Mets at DX CS Site-Specific Factor 4 - Levels IV- CS Mets Eval V and Retropharyngeal Lymph Nodes for Head and Neck CS Site-Specific Factor 5 - Levels VI- VII and Facial Lymph Nodes for Head and Neck CS Site-Specific Factor 6 - Parapharyngeal, Parotid, Preauricular, and Sub-Occipital Lymph Nodes, Lymph Nodes for Head and Neck Nasal Cavity CS Tumor Size SEE STANDARD TABLE Nasal Cavity CS Extension Code Description TNM SS77 SS2000 00 In situ; non-invasive Tis IS IS 10 Invasive tumor confined to site of origin T1 L L Meatus (superior, middle, inferior) Nasal chonchae (superior, middle, inferior) Septum Tympanic membrane 30 Localized, NOS T1 L L 40 Extending to adjacent connective tissue within the nasoethomoidal T2 RE RE complex Nasolacrimal duct 60 Adjacent organs/structures including: T3 RE RE Bone of skull Choana Frontal sinus Hard palate
    [Show full text]
  • Ministry of Education and Science of Ukraine Sumy State University 0
    Ministry of Education and Science of Ukraine Sumy State University 0 Ministry of Education and Science of Ukraine Sumy State University SPLANCHNOLOGY, CARDIOVASCULAR AND IMMUNE SYSTEMS STUDY GUIDE Recommended by the Academic Council of Sumy State University Sumy Sumy State University 2016 1 УДК 611.1/.6+612.1+612.017.1](072) ББК 28.863.5я73 С72 Composite authors: V. I. Bumeister, Doctor of Biological Sciences, Professor; L. G. Sulim, Senior Lecturer; O. O. Prykhodko, Candidate of Medical Sciences, Assistant; O. S. Yarmolenko, Candidate of Medical Sciences, Assistant Reviewers: I. L. Kolisnyk – Associate Professor Ph. D., Kharkiv National Medical University; M. V. Pogorelov – Doctor of Medical Sciences, Sumy State University Recommended for publication by Academic Council of Sumy State University as а study guide (minutes № 5 of 10.11.2016) Splanchnology Cardiovascular and Immune Systems : study guide / С72 V. I. Bumeister, L. G. Sulim, O. O. Prykhodko, O. S. Yarmolenko. – Sumy : Sumy State University, 2016. – 253 p. This manual is intended for the students of medical higher educational institutions of IV accreditation level who study Human Anatomy in the English language. Посібник рекомендований для студентів вищих медичних навчальних закладів IV рівня акредитації, які вивчають анатомію людини англійською мовою. УДК 611.1/.6+612.1+612.017.1](072) ББК 28.863.5я73 © Bumeister V. I., Sulim L G., Prykhodko О. O., Yarmolenko O. S., 2016 © Sumy State University, 2016 2 Hippocratic Oath «Ὄμνυμι Ἀπόλλωνα ἰητρὸν, καὶ Ἀσκληπιὸν, καὶ Ὑγείαν, καὶ Πανάκειαν, καὶ θεοὺς πάντας τε καὶ πάσας, ἵστορας ποιεύμενος, ἐπιτελέα ποιήσειν κατὰ δύναμιν καὶ κρίσιν ἐμὴν ὅρκον τόνδε καὶ ξυγγραφὴν τήνδε.
    [Show full text]
  • Download Download
    ACTA Official Journal of the Italian Society Otorhinolaryngologica Italica, 38/2, Supplement 1, S1-S106, 2018 S1-S106, Supplement 1, 38/2, Otorhinolaryngologica Italica, of Otorhinolaryngology Head and Neck Surgery Organo Ufficiale della Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale 105th Congress of the Italian Society of Otorhinolaryngology Head and Neck Surgery Official report Emerging and re-emerging infectious disease in otorhinolaryngology Patologia infettiva emergente e riemergente in otorinolaringoiatria F. Scasso, G. Ferrari, G.C. De Vincentiis, A. Arosio, S. Bottero, M. Carretti, A. Ciardo, S. Cocuzza, A. Colombo, B. Conti, A. Cordone, M. De Ciccio, E. Delehaye, L. Della Vecchia, I. De Macina, C. Dentone, P. Di Mauro, R. Dorati, R. Fazio, A. Ferrari, G. Ferrea, S. Giannantonio, I. Genta, M. Giuliani, D. Lucidi, L. Maiolino, G. Marini, P. Marsella, D. Meucci, T. Modena, B. Montemurri, A. Odone, S. Palma, M.L. Panatta, M. Piemonte, P. Pisani, S. Pisani, L. Prioglio, A. Scorpecci, L. Scotto di Santillo, A. Serra, C. Signorelli, E. Sitzia, M.L. Tropiano, M. Trozzi, F.M. Tucci, L. Vezzosi, B. Viaggi Volume 38 • Supplement 1 April 2018 POSTE ITALIANE SPA - Spedizione in Abbonamento Postale - D.L. 353/2003 conv. in L. 27/02/2004 n° 46 art. 1, comma 1, DCB PISA - Iscrizione al tribunale di Pisa al n. 10 del 30-07-93 - ISSN: 0392-100X (Print) - ISSN: 1827-675X (Online) 10 del 30-07-93 - ISSN: DCB PISA - Iscrizione al tribunale di Pisa n. comma 1, 1, 27/02/2004 n° 46 art. in L. 353/2003 conv. Abbonamento Postale - D.L.
    [Show full text]
  • Metastasis of Lower Gingival Squamous Cell Carcinoma To
    Takada et al. World Journal of Surgical Oncology (2019) 17:13 https://doi.org/10.1186/s12957-019-1559-y CASE REPORT Open Access Metastasis of lower gingival squamous cell carcinoma to buccinator lymph node: case report and review of the literature Kaho Takada1, Takeshi Kuroshima1* , Hiroaki Shimamoto1, Toshimitsu Ohsako1, Kou Kayamori2, Tohru Ikeda2 and Hiroyuki Harada1 Abstract Background: Metastasis of oral cancer to the buccinator lymph nodes (BN) is uncommon. The antegrade lymphatic flow in patients with normal anatomy and physiology makes metastasis of lower gingival cancer to BN unlikely. Case presentation: A 67-year-old woman presented with a 46 × 25-mm tumor on her lower gingiva, along with metastatic foci in BN and cervical lymph nodes. After neoadjuvant chemotherapy, she underwent radical resection of the primary tumor and BN, along with neck dissection. Following surgery, she received adjuvant chemoradiotherapy. Two years after treatment, there has been no evidence of tumor recurrence or metastasis. Conclusion: This is the first report of lower gingival squamous cell carcinoma with metastasis to BN. Metastasis to BN from lower gingival cancer is very rare but should be considered in patients with locally advanced tumors or tumors that metastasize to the submandibular node. Keywords: Buccinator lymph nodes, Facial lymph nodes, Metastasis, Oral cancer, Squamous cell carcinoma Background gingiva (Fig. 1). A submucosal mass, independent of Metastasis to the lymph nodes is the most prognostic the gingival tumor, was palpable in the left buccal re- factor in patients with oral cancer. Primary cancers in gion. Several cervical lymph nodes on the left side the oral region frequently metastasize to level I–III were also palpable.
    [Show full text]
  • Incidence, Morbidity and Mortality of Patients with Achalasia in England: Findings from a Nationwide Hospital Database and 4 Million Population Based Data
    Incidence, morbidity and mortality of patients with achalasia in England: findings from a nationwide hospital database and 4 million population based data Appendix A: International Classification of Disease codes for Achalasia (HES) K22 – Achalasia of cardia Appendix B: Read codes (The Health Improvement Network) Appendix B1: Achalasia codes Clinical code Description J100.00 Achalasia of cardia Appendix B2: Clinical codes used to identify Hypertension, Diabetes and lipid lowering drugs Diabetes Clinical code Description C10..00 Diabetes mellitus C100.00 Diabetes mellitus with no mention of complication C100000 Diabetes mellitus, juvenile type, no mention of complication C100011 Insulin dependent diabetes mellitus C100100 Diabetes mellitus, adult onset, no mention of complication C100111 Maturity onset diabetes C100112 Non-insulin dependent diabetes mellitus C100z00 Diabetes mellitus NOS with no mention of complication C101.00 Diabetes mellitus with ketoacidosis C101000 Diabetes mellitus, juvenile type, with ketoacidosis C101100 Diabetes mellitus, adult onset, with ketoacidosis C101y00 Other specified diabetes mellitus with ketoacidosis C101z00 Diabetes mellitus NOS with ketoacidosis C102.00 Diabetes mellitus with hyperosmolar coma C102000 Diabetes mellitus, juvenile type, with hyperosmolar coma C102100 Diabetes mellitus, adult onset, with hyperosmolar coma C102z00 Diabetes mellitus NOS with hyperosmolar coma C103.00 Diabetes mellitus with ketoacidotic coma C103000 Diabetes mellitus, juvenile type, with ketoacidotic coma C103100 Diabetes
    [Show full text]
  • Review of the Superficial Head and Neck Lymphatic System
    Journal of Radiology and Imaging An Open Access Publisher Bou-Assaly W, J Radiol Imaging. 2016, 1(1):9-13 http://dx.doi.org/10.14312/2399-8172.2016-3 Review Open Access The forgotten lymph nodes: Review of the superficial head and neck lymphatic system Wessam Bou-Assaly1, 1 Department of Radiology, Habib Medical Group, United Arab Emirates Abstract In patients with head and neck malignancy, knowledge of the lymphatic pathways relevant to tumor location is important for treatment preparation, both in radiation therapy and in surgery. The lymphatics of the head and neck area consist of superficial and deep nodes groups, which are connected by numerous small vessels, giving rise to a complex subcutaneous and deep lymphatic network. The deep cervical lymph nodes, mainly placed along the jugulo carotid vessels, have been intensively reviewed in radiology and classified by well- established levels. The more superficial groups, notably the occipital, parotid, mastoid, facial and superficial cervical lymph nodes groups were not well recognized in the radiology literature, probably because of their less frequent involvement in the more predominant pharyngeal and laryngeal mucosal malignancy, and seem to have been forgotten. We present a review of the anatomy of those lymph nodes groups, including their location, afferent and efferent drainage tracts accompanied by cross-sectional imaging CT examples. Keywords: lymph nodes; head and neck; lymphatic system Introduction Rouvière classified the lymph nodes of the head and neck into 10 groups. The most superficial ones, namely the occipital, parotid, facial and mastoid groups, situated at the junction of head and neck, form a veritable lymphoid collar that he designated as pericervical lymphoid ring (Figure 1a) [1, 2].
    [Show full text]
  • Atlas of Topographical and Pathotopographical Anatomy of The
    Contents Cover Title page Copyright page About the Author Introduction Part 1: The Head Topographic Anatomy of the Head Cerebral Cranium Basis Cranii Interna The Brain Surgical Anatomy of Congenital Disorders Pathotopography of the Cerebral Part of the Head Facial Head Region The Lymphatic System of the Head Congenital Face Disorders Pathotopography of Facial Part of the Head Part 2: The Neck Topographic Anatomy of the Neck Fasciae, Superficial and Deep Cellular Spaces and their Relationship with Spaces Adjacent Regions (Fig. 37) Reflex Zones Triangles of the Neck Organs of the Neck (Fig. 50–51) Pathography of the Neck Topography of the neck Appendix A Appendix B End User License Agreement Guide 1. Cover 2. Copyright 3. Contents 4. Begin Reading List of Illustrations Chapter 1 Figure 1 Vessels and nerves of the head. Figure 2 Layers of the frontal-parietal-occipital area. Figure 3 Regio temporalis. Figure 4 Mastoid process with Shipo’s triangle. Figure 5 Inner cranium base. Figure 6 Medial section of head and neck Figure 7 Branches of trigeminal nerve Figure 8 Scheme of head skin innervation. Figure 9 Superficial head formations. Figure 10 Branches of the facial nerve Figure 11 Cerebral vessels. MRI. Figure 12 Cerebral vessels. Figure 13 Dural venous sinuses Figure 14 Dural venous sinuses. MRI. Figure 15 Dural venous sinuses Figure 16 Venous sinuses of the dura mater Figure 17 Bleeding in the brain due to rupture of the aneurism Figure 18 Types of intracranial hemorrhage Figure 19 Different types of brain hematomas Figure 20 Orbital muscles, vessels and nerves. Topdown view, Figure 21 Orbital muscles, vessels and nerves.
    [Show full text]
  • NHSCR Data Collection Manual 2011
    FORDS Facility Oncology Registry Data Standards Revised for 2011 (Incorporates all updates since FORDS was originally published in July 2002) Includes updates to January 1, 2011 See Appendix C for a summary of changes. © 2002 AMERICAN COLLEGE OF SURGEONS All Rights Reserved ii Table of Contents Preface 2010.......................................................................................................................... xi SECTION ONE: Case Eligibility and Overview of Coding Principles........................... 1–31 Case Eligibility ............................................................................................................... 3 Tumors Required by the CoC to be Accessioned, Abstracted, and Followed........... 3 Reportable-by-Agreement Cases............................................................................... 3 Ambiguous Terms at Diagnosis................................................................................. 3 Class of Case.............................................................................................................. 5 Date of First Contact.................................................................................................. 5 Overview of Coding Principles ..................................................................................... 7 Unique Patient Identifier Codes................................................................................. 7 National Provider Identifier......................................................................................
    [Show full text]
  • The Veterinary Journal the Veterinary Journal 175 (2008) 379–383
    Available online at www.sciencedirect.com The Veterinary Journal The Veterinary Journal 175 (2008) 379–383 www.elsevier.com/locate/tvjl The buccal lymph node (lymphonodus buccalis) in dogs: Occurrence, anatomical location, histological characteristics and clinical implications Christophe R. Casteleyn a,*, Maartje van der Steen a, Jan Declercq b, Paul Simoens a a Department of Morphology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium b Department of Small Animal Medicine and Clinical Biology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium Accepted 28 January 2007 Abstract Three dogs were presented for clinical examination with bilateral buccal nodules which were identified as enlarged buccal lymph nodes. As little is known about this pathology, 150 dogs were examined by anatomical dissection for the presence of buccal lymph nodes. They were found in 13 dogs, occurring bilaterally in six dogs and unilaterally in seven dogs. Two buccal lymph nodes were bilobulated and one was double. The lymph nodes were always located dorsal to the zygomatic muscle and rostral to the masseter muscle in the region where the superior labial vein drains into the facial vein. Histology demonstrated a large amount of intranodal adipose tissue scattered throughout the lymphoid tissue. The canine buccal lymph node should not be confused with the accessory parotid or ventral buccal salivary gland and is clinically important as it can enlarge due to tumour metastasis or inflammation of the buccal region. Ó 2007 Elsevier Ltd. All rights reserved. Keywords: Anatomy; Buccal nodule; Dog; Histology; Lymphatic system 1. Introduction skin biopsy specimens revealed cutaneous non-epitheliotro- pic lymphoma.
    [Show full text]
  • POLICY and PROCEDURE MANUAL Facility-Based Registry Edition
    WEST VIRGINIA DEPARTMENT OF HEALTH AND HUMAN RESOURCES West Virginia Cancer Registry 2 0 0 7 POLICY AND PROCEDURE MANUAL Facility-Based Registry Edition Bureau for Public Health 350 Capitol Street, Room 125 Charleston, WV 25301 Joe Manchin III, Governor Martha Yeager Walker, Secretary 2007 Policy and Procedure Manual Facility-Based Registry Edition Joe Manchin III Governor Martha Yeager Walker Secretary, Department of Health and Human Resources Chris Curtis, MPH Acting Commissioner, Bureau for Public Health Catherine Slemp, MD, MPH Acting State Health Officer, Bureau for Public Health Joe Barker, MPA Director, Office of Epidemiology and Health Promotion Loretta Haddy, PhD Director, Division of Surveillance and Disease Control Patricia Colsher, PhD Director/Epidemiologist, West Virginia Cancer Registry Cover images courtesy of the National Cancer Institute Visuals Online. Top left: Medulloblastoma. Top right: Ependymoma. Lower left: Oligodendroglioma. Lower right: Glioblastoma. Manual Prepared and Cover Design, Graphics and Layout by: Patricia Colsher, PhD Director/Epidemiologist, West Virginia Cancer Registry Materials Reviewed by: Darlene Maxwell, CTR Leslie Boner, CTR Lee Ann Phalen, CTR WVCR Data Quality Staff WVCR Staff Patricia Colsher, PhD Director/Epidemiologist Darlene Maxwell, CTR Data Quality/Training Leslie Boner, CTR Data Quality/Training Lee Ann Phalen, CTR Data Quality/Training R. Neal Kerley, CTR Systems Management Brenda Shehab Surveillance Stephen Williams Surveillance Judy Arbogast Surveillance Jena Webb Support Services
    [Show full text]
  • FORDS for 2011
    FORDS Facility Oncology Registry Data Standards Revised for 2011 (Incorporates all updates since FORDS was originally published in July 2002) Includes updates to January 1, 2011 See Appendix C for a summary of changes. © 2002 AMERICAN COLLEGE OF SURGEONS All Rights Reserved ii Table of Contents Preface 2010.......................................................................................................................... xi SECTION ONE: Case Eligibility and Overview of Coding Principles........................... 1–31 Case Eligibility ............................................................................................................... 3 Tumors Required by the CoC to be Accessioned, Abstracted, and Followed........... 3 Reportable-by-Agreement Cases............................................................................... 3 Ambiguous Terms at Diagnosis................................................................................. 3 Class of Case.............................................................................................................. 5 Date of First Contact.................................................................................................. 5 Overview of Coding Principles ..................................................................................... 7 Unique Patient Identifier Codes................................................................................. 7 National Provider Identifier......................................................................................
    [Show full text]